The store will not work correctly when cookies are disabled.
ethyl 2-(3-benzhydrylureido)acetate
ID: ALA4741383
PubChem CID: 21659776
Max Phase: Preclinical
Molecular Formula: C18H20N2O3
Molecular Weight: 312.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)CNC(=O)NC(c1ccccc1)c1ccccc1
Standard InChI: InChI=1S/C18H20N2O3/c1-2-23-16(21)13-19-18(22)20-17(14-9-5-3-6-10-14)15-11-7-4-8-12-15/h3-12,17H,2,13H2,1H3,(H2,19,20,22)
Standard InChI Key: ZGFKSNVTMHQTJZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
28.4223 -19.8326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1374 -20.2412 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8511 -19.8257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5662 -20.2386 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8496 -19.0015 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.2798 -19.8231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9949 -20.2360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7086 -19.8205 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.9964 -21.0603 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.4237 -20.2334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1332 -19.8179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7127 -20.2439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4208 -19.0041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0009 -19.8268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2877 -20.2415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2888 -21.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0090 -21.4795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7193 -21.0623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1374 -18.5969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1362 -17.7733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4206 -17.3596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7087 -17.7795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7134 -18.6017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
3 5 2 0
4 6 1 0
6 7 1 0
7 8 1 0
7 9 2 0
8 10 1 0
10 11 1 0
1 12 1 0
1 13 1 0
12 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 12 1 0
13 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 13 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 312.37 | Molecular Weight (Monoisotopic): 312.1474 | AlogP: 2.64 | #Rotatable Bonds: 6 |
Polar Surface Area: 67.43 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.57 | CX LogD: 2.57 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.81 | Np Likeness Score: -1.21 |
References
1. Harrison D,Boutard N,Brzozka K,Bugaj M,Chmielewski S,Cierpich A,Doedens JR,Fabritius CRY,Gabel CA,Galezowski M,Kowalczyk P,Levenets O,Mroczkowska M,Palica K,Porter RA,Schultz D,Sowinska M,Topolnicki G,Urbanski P,Woyciechowski J,Watt AP. (2020) Discovery of a series of ester-substituted NLRP3 inflammasome inhibitors., 30 (23): [PMID:32956781] [10.1016/j.bmcl.2020.127560] |